Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4105571 | 0.85 | SCN9A (0.32) | SCN9A | |
| SCHEMBL4110572 | 0.81 | SCN9A (0.32) | SCN9A | |
| SCHEMBL10150633 | 0.78 | ALDH1A1 (0.32) | — | |
| SCHEMBL3218526 | 0.77 | HSD11B1 (0.41) | — | |
| SCHEMBL12892479 | 0.74 | HSD11B1 (0.39) | — | |
| SCHEMBL17563397 | 0.73 | — | — | |
| SCHEMBL418793 | 0.72 | HSD11B1 (0.44) | — | |
| SCHEMBL3338491 | 0.72 | — | — | |
| SCHEMBL13608630 | 0.72 | NPSR1 (0.45) | SCN9A | |
| SCHEMBL15182752 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156854-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-7528279-B2 | Adamantane derivatives and process for producing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-05 | — | — | US | disclosed |
| US-20070129532-A1 | Adamantane derivatives and process for producing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1712542-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156854-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | ADH1A, ADH5, TAS1R2 | SCN9A 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.